Amundi Private Equity Funds Life Sciences

https://www.amundi-pef.com

With more than €7 billion in assets under management (at 30 September 2017), Amundi Private Equity Funds offers its retail and institutional clients a wide range of products tailored to their needs. Clients can invest in two types of products: direct funds dedicated to acquiring direct holdings in non-listed companies (in development and transfer phases), and funds of funds dedicated to investing in private equity, private debt and infrastructure funds. Amundi PEF supports companies in development and transmission stages. Amundi PEF is an authorized management company fully-owned by Amundi. *

	Start	2011-07-14 existent
	Group	Amundi (Group)
	Industry	private equity

	Region	Paris
	Country	France
	Street	128-130 boulevard Raspail
	City	75006 Paris
		Address record changed: 2020-12-02

Basic data	Employees	C: 51 to 100 (2011-07-23)
	Currency	EUR
	Annual sales	690,500,000,000 (capital under management 2011-07-23)

		* Document for »About Section«: HalioDx SAS. (1/17/18). "Press Release: HalioDx Closed a Series B round of €18.5 Million (US$22.3 Million)". Marseille.

		Record changed: 2024-02-12

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)